Investigators & Publications

Each year, GRIP awards 8-10 recipients a grant for research. Several grant investigators have published over the years. Please find them highlighted below. Additionally, most abstracts can be located on Pub Med.

2010 - Cycle 9
Humphreys, Benjamin
INSTITUTE: Harvard Medical School, MA, USA

PROPOSAL NAME:
Translational Profiling of Vasculature in Chronic Kidney Disease
Li, Yan Chun
INSTITUTE: University of Chicago, IL, USA

PROPOSAL NAME:
Epigenetic Regulation Glomerulosclerosis in Diabetic Nephropathy
Moe, Orson
INSTITUTE: UT Southwestern Medical Center, USA

PROPOSAL NAME:
Epigenetic Regulation of Erythropoietin Receptor in the Kidney by Natural Antisense Transcript
Mrug, Michal
INSTITUTE: University of Alabama, USA

PROPOSAL NAME:
Unmasking epigenetic profiles of renal cystogenesis
Pontoglio, Marco
INSTITUTE: INSERM, Paris, France

PROPOSAL NAME:
HNF1beta/MODY5 and the epigenetic postmitotic gene expression reprogramming
Vanden Heuvel, Gregory
INSTITUTE: University of Kansas Medical Center, USA

PROPOSAL NAME:
Expression of p27 in polycystic kidney disease
Wheeler, David
INSTITUTE: UCL Medical School, London, UK

PROPOSAL NAME:
P2X7 purinoreceptor: A novel target for ameliorating vascular calcification
Zeisberg, Michael
INSTITUTE: Harvard Medical School, MA, USA

PROPOSAL NAME:
Mechanisms of Hypermethylation in Progression of Chronic Kidney Disease
2009 - Cycle 8
Duffield, Jeremy
INSTITUTE: Brigham & Women's Hosp, Boston, MA USA

PROPOSAL NAME:
The role of FCγ receptor ligation by pentraxins, serum Amyloid P and C Reactive Protein in renal fibrosis
Huang, Chou-Long
INSTITUTE: UT Southwestern Medical Center, USA

PROPOSAL NAME:
Klotho protection of glomerular proteinuria via TRPC6
Miller, Barbara
INSTITUTE: Penn State University, USA

PROPOSAL NAME:
TRPM2 in acute renal injury
Nijenhuis, Tom
INSTITUTE: Radboud University Nijmegen, Netherlands

PROPOSAL NAME:
Regulation of TRPC6 expression and activity in podocytes by RAAS, glucose and vitamin D
Reiser, Jochen
INSTITUTE: University of Miami, USA

PROPOSAL NAME:
TRPC6 signals affecting the podocyte cytoskeleton during proteinuria-chances for intervention
Robson, Michael
INSTITUTE: King's College London, UK

PROPOSAL NAME:
The role of Toll-like receptor 2 and 4 in antineutrophil cytosplamic antibody-associated vasculitis
White, Kenneth
INSTITUTE: Indiana University School of Medicine, USA

PROPOSAL NAME:
FGF23-FGFR interactions to maintain phosphate balance in CKD

PUBLICATION(s):
Farrow EG and White KE. Recent advances in renal phosphate handling. Invited review. Nature Reviews Nephrology. 2010 Apr;6(4):207-17
Farrow E, Summers L, Schiavi S, et al. Altered Renal FGF23-Mediated Activity Involving MAPK and Wnt: Effects of the Hyp Mutation. J Endocrinol. 2010; Jul 30.
Zheng, Feng
INSTITUTE: Mount Sinai School of Medicine, NY, USA

PROPOSAL NAME:
AGE mediated TLR4 activation and kidney aging

2008 - Cycle 7
Badano, Jose
INSTITUTE: Institut Pasteur de Montevideo, Uruguay

PROPOSAL NAME:
The role of MGC1203, a second site modifier of Bardet-Biedl syndrome, in cell fate decisions

PUBLICATION(s):
Cardenas-Rodriguez M and Badano J. Ciliary Biology: Understanding the Cellular and Genetic Basis of Human Ciliopathies. American Journal of Medical Genetics Part C (Seminars in Medical Genetics). 2009; 151C:263–280
Benigni, Ariela
INSTITUTE: Mario Negri Institute, Bergamo, Italy

PROPOSAL NAME:
Mesenchymal stem cell-derived exosomes reprogram damaged renal tubular cells by horizontal transfer of mRNA, microRNA and protein delivery
Bou-Gharios, George
INSTITUTE: Imperial College London, UK

PROPOSAL NAME:
Stem cell mediated renal repair in an Alport syndrome mouse model
Feng, Jerry (Jian)
INSTITUTE: Texas A&M HSC, Baylor College, USA

PROPOSAL NAME:
Disturbance of phosphate homeostasis changes osteocyte morphology and function

PUBLICATION(s):
Lu Y, Yuan B, Qin C, et al. The biological function of DMP1 in osteocyte maturation is mediated by its 57 kDa C-terminal fragment. Journal of Bone and Mineral Research. 2010 Aug 23.
Lu Y, Feng JQ. FGF23 in skeletal modeling and remodeling. Curr Osteoporos Rep. 2011 Jun;9(2):103-8.
Zhang R, Lu Y, Ye L, et al. Unique Roles of Phosphorus in Endochondral Bone Formation and Osteocyte Maturation. Bone Miner Res. 2011 May;26(5):1047-56. doi: 10.1002/jbmr.294.
Lu Y, Yuan B, Qin C, et al. The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment. J Bone Miner Res. 2011 Feb;26(2):331-40. doi: 10.1002/jbmr.226.
Kaplan, David
INSTITUTE: Tufts University, MA, USA

PROPOSAL NAME:
In vitro 3D tissue model for kidney disease responses
Kuro-o, Makoto
INSTITUTE: UT Southwestern Medical Center, USA

PROPOSAL NAME:
Effects of Klotho ectodomain shedding on phosphate metabolism
Salama, Alan
INSTITUTE: Imperial College London, UK

PROPOSAL NAME:
Investigating leukocyte chemotaxis in the pathogenesis of ANCA associated vasculitis and glomerulonephritis
Shah, Jagesh
INSTITUTE: Brigham & Women's Hosp, Boston, MA USA

PROPOSAL NAME:
Cilium-based signaling during tubulogenesis and cystogenesis
Smeets, Bart
INSTITUTE: University Hospital Aachen, Germany

PROPOSAL NAME:
Chemokine receptor CXCR4 and CXCR7 signaling plays a crucial role in glomerular regeneration and development of proliferative glomerular lesions
Stubbs, Jason
INSTITUTE: University of Kansas Medical Center, USA

PROPOSAL NAME:
Elucidating the role of FGF23 in disordered mineral metabolism in CKD using mouse genetic approaches
2007 - Cycle 6
Dwyer, Karen
INSTITUTE: St. Vincent's Health, Melbourne, Australia

PROPOSAL NAME:
CD39 protects against renal ischemia-reperfusion injury through the inhibition of NKT cells

PUBLICATION(s):
Lu B, Rajakumar V, Robson S, et al. The Impact of Purinergic Singnaling on Renal Ischemia-Reperfusion Injury. Transplantation. 2008;86: 1707-1712.
Hughes, Jeremy
INSTITUTE: University of Edinburgh, UK

PROPOSAL NAME:
Macrophage trafficking to and from the inflamed tubulointerstitium
Humphreys, Benjamin
INSTITUTE: Harvard Medical School, MA, USA

PROPOSAL NAME:
Genetic tracking of adult kidney progenitors in renal repair

PUBLICATION(s):
Humphreys B, Valerius M, Kobayashi A, et al. Intrinsic Epithelial Cells Repair the Kidney after Injury. Cell Stem Cell. 2008; 2, 284-291.
Song J, Czerniak S, Wang T, et al. Characterization and Fate of Telomerase-expressing Epithelia during Kidney Repair. J Am Soc Nephrol. 2011 Oct 21.
Kitching, Richard
INSTITUTE: Monash Medical Centre, Australia

PROPOSAL NAME:
Mechanisms of leukocyte activation and adherence in glomeruli in ANCA-associated glomerulonephritis in vivo

PUBLICATION(s):
Kumar, Rajiv
INSTITUTE: Mayo Clinic, NY, USA

PROPOSAL NAME:
Identification of novel intestinal factors that rapidly alter phosphate transport
Moe, Sharon
INSTITUTE: Indiana University School of Medicine, USA

PROPOSAL NAME:
The role of Vitamin D in immune function in patients with CKD Stages 3 & 4
Nikolic-Paterson, David
INSTITUTE: Monash Medical Centre, Australia

PROPOSAL NAME:
Regulation of macrophage and T cell mediated renal injury via indoleamine 2,3-dioxygenase
Okusa, Mark
INSTITUTE: University of Virginia, USA

PROPOSAL NAME:
Kidney resident dendritic cells activate the IL-12/IFN-γ and IL-23/IL-17 axis initiating early renal IRI
Rabb, Hamid
INSTITUTE: Johns Hopkins University, MD, USA

PROPOSAL NAME:
Identification of inducible peptides that modulate leukocyte adhesion and inflammation during ischemic acute kidney injury
van Zonneveld, Anton-Jan
INSTITUTE: Leiden Univ Medical Ctr, The Netherlands

PROPOSAL NAME:
Exploring the role of microRNAs in renal endothelial regeneration

PUBLICATION(s):
van Solingen C, Seghers L, Bijkerk R, et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J. Cell. Mol. Med. 2009;Vol 13, No 2, pp. 1-9.
2006 - Cycle 5
Alpers, Charles
INSTITUTE: University of Washington, Seattle, USA

PROPOSAL NAME:
Pathogenicity of foam cells in chronic renal disease
Duffield, Jeremy
INSTITUTE: Brigham & Women's Hosp, Boston, MA USA

PROPOSAL NAME:
Understanding the mechanisms of macrophage mediated progressive kidney disease

PUBLICATION(s):
Lin S, Kisseleva T, Brenner D, et al. Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney. The American Journal of Pathology., 2008;Vol. 173, No. 6.
Lin S, Castano A, Nowlin B, et al. Bone Marrow Ly6Chigh Monocytes Are Selectively Recruited to Injured Kidney and Differentiate into Functionally Distinct Populations. The Journal of Immunology. 2009; Nov 15;183(10):6733-43.
Castaño A, Lin S, Surowy T, et al. Serum Amyloid P Inhibits Fibrosis Through FcgR-Dependent Monocyte-Macrophage Regulation in Vivo. Science Translational Medicine., 2009; 4 November Vol 1 Issue 5 5ra13.
Lin S, Li B, Rao S, et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA. 2010 Mar 2;107(9):4194-9.
Gross, ML & Melk, A
INSTITUTE: University of Heidelberg, Germany

PROPOSAL NAME:
The role of cellular senescence in accelerated atherogenesis of renal disease - human and experimental studies
Harris, Raymond
INSTITUTE: Vanderbilt University Medical Ctr, TN USA

PROPOSAL NAME:
Role of endothelial dysfunction due to eNOS deficiency in diabetic nephropathy
Hughey, Rebecca
INSTITUTE: University of Pittsburgh, PA USA

PROPOSAL NAME:
The role of MUC1 in EGF receptor apical expression

PUBLICATION(s):
Mattila P, Kinlough C, Bruns J, et al. MUC1 traverses apical recycling endosomes along the biosynthetic pathway in polarized MDCK cells. Biol. Chem. 2009; Jul 390(7):551-6.
Poland P, Rondanino C, Kinlough CL, et all. Identification and characterization of endogenous galectins expressed in Madin Darby canine kidney cells. J. Biol. Chem.. 2011 Feb 25;286(8):6780-90. Epub 2010 Dec 2.
Kelley, Vicki
INSTITUTE: Brigham & Women's Hosp, Boston, MA USA

PROPOSAL NAME:
The PD-1 negative regulatory pathway in macrophage mediated renal inflammation

PUBLICATION(s):
Menke J, Lucas J, Zeller G, et al. Programmed Death 1 Ligand (PD-L) 1 and PD-L2 Limit Autoimmune Kidney Disease: Distinct Roles The Journal of Immunology. 2007;0022-1767/07
Lucas J, Menke J, Rabacal W, et al. Programmed Death Ligand 1 Regulates a Critical Checkpoint for Autoimmune Myocarditis and Pneumonitis in MRL Mice. The Journal of Immunology. 2008;0022-1767/08
Levine, Jerrold
INSTITUTE: University of Illinois at Chicago, USA

PROPOSAL NAME:
The role of the default pathway in recovery from acute renal injury

PUBLICATION(s):
Antoni A, Graham L, Rauch J, et al. Altered cell–cell and cell–matrix interactions in the development of systemic autoimmunity. Autoimmunity. 2009; 42(4): 278–281
Lieberthal W and Levine J. The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease. J Am Soc Nephrol. 2009; 20: 2493–2502
Dieude M, Gillis M, Theoret J, et al. Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis. Journal of Thrombosis and Haemostasis. 2009;7: 710–719.
Patel V, Lee D, Feng L, et al. Recognition of Apoptotic Cells by Epithelial Cells. The Journal of Biological Chemistry. 2010;Vol. 285, NO. 3, pp. 1829-1840.
Ma, Li-Jun
INSTITUTE: Vanderbilt University Medical Ctr, TN USA

PROPOSAL NAME:
Perlecan heparan sulfate modulation of podocytes and endothelial cells in diabetic nephropathy
Molema, Grietje
INSTITUTE: UMC Groningen, The Netherlands

PROPOSAL NAME:
Re(n)ality: Unmasking the true identities of the vascular endothelial cells that control renal diseases
Morigi, Marina
INSTITUTE: Mario Negri Institute, Bergamo, Italy

PROPOSAL NAME:
Role of complement in Shiga toxin-induced microvascular thrombosis: In vitro and in vivo models of Hemolytic Uremic Syndrome

2005 - Cycle 4
Antignac, C. & Esquivel, E.
INSTITUTE: Hospital Necker, Paris, France

PROPOSAL NAME:
The role of podocin in vascular development and remodeling during the progression of nephrotic syndrome

PUBLICATION(s):
Ratelade J, Lavin TA, Muda AO, et al. Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome. J Am Soc Nephrol. 2008 Aug;19(8):1491-9.
Dockrell, M. & Colville-Nash, P.
INSTITUTE: Thames Institute, Surrey, UK

PROPOSAL NAME:
The role of Id2 in TGF-β and BMP-7 signalling in the proximal tubule and its role in EMT
Féraille, Eric
INSTITUTE: University Hospital Geneva, Switzerland

PROPOSAL NAME:
Stimulation of renal sodium transport as a potential promoter of inflammation and fibrosis through activation of NK-ĸB

PUBLICATION(s):
Leroy V, De Seigneux S, Agassiz V, et al. Aldosterone Activates NF-kB in the Collecting Duct. J Am Soc Nephrol. 2009;20:131-144.
Kirby, John
INSTITUTE: University of Newcastle, UK

PROPOSAL NAME:
Chronic renal allograft nephropathy: do TGF-β expressing 'regulatory' T cells induce tubular epithelial to mesenchymal cell transition?
Kon, Valentina
INSTITUTE: Vanderbilt University Medical Ctr, TN USA

PROPOSAL NAME:
The role of angiotensin II in renal dysfunction-acceleration of atherosclerosis
Pollak, Martin
INSTITUTE: Brigham & Women's Hosp, Boston, MA USA

PROPOSAL NAME:
Identification of the genetic basis of FSGS in African-Americans using admixture mapping
Quaggin, Susan
INSTITUTE: Mount Sinai, Toronto, ON

PROPOSAL NAME:
The role of the VHL-HIF pathway in podocyte biology
Ronco, Pierre
INSTITUTE: Tenon Hospital, Paris, France

PROPOSAL NAME:
Molecular pathomechanisms of renal diseases induced by allo-immunization: Identification of pathogenic antigens and epitopes and development of antigen-specific therapy via nasal tolerance

PUBLICATION(s):
Ronco P, Debiec H. New insights into membranous glomerulonephritis. Curr Opin Nephrol Hypertens 2006, 15(3): 258-63.
Debiec H, Ronco M. Fetomaternal alloimmunization with antenatal glomerulopathies. Ann NY Acad Sci, 2007, 1110:559-66.
Ronco P, Debiec H. Podocyte Antigens and Glomerular Disease Nephron Exp Nephrol. 2007, 107:41-46.
Ronco P, Debiec H. Target antigens and nephritogenic antibodies in membranous nephropathy : of rats and men Seminars in Immunopathol. 2007, 29:45-58.
Ronco P, Debiec H. Target antigens and nephritogenic antibodies in membranous nephropathy. Arch Med Sci, 2009, 5 : S442-S450.
Thameem, Farook
INSTITUTE: University of Texas San Antonio, USA

PROPOSAL NAME:
Genetics of diabetic kidney disease
Zandi-Nejad, Kambiz
INSTITUTE: Brigham & Women's Hosp, Boston, MA USA

PROPOSAL NAME:
The role of novel anion transporters SLC5A8 and SLC5A12 in renal urate transport
2004 - Cycle 3
Bluyssen, H & Braam, GB
INSTITUTE: UMC Utrecht, The Netherlands

PROPOSAL NAME:
Chronic renal failure-induced dysbalance of JAK/STAT signaling differentially affects pro- and anti-inflammatory signals and accelerates atherosclerosis
Bradley, John
INSTITUTE: Addenbrooke's Hospital, UK

PROPOSAL NAME:
Death receptor-3 in renal inflammation and injury

PUBLICATION(s):
Al-Lamki R, Wang J, Tolkovsky A, et al. TL1A Both Promotes and Protects from Renal Inflammation and Injury. J Am Soc Nephrol. 2008;19: 953-960.
Karl, Michael
INSTITUTE: Vascular Biology Institute, Miami FL USA

PROPOSAL NAME:
Preventing the development and progression of diabetic glomerulosclerosis by inhibition of mineralocorticoid receptor action
Noris, Marina
INSTITUTE: Mario Negri Institute, Bergamo, Italy

PROPOSAL NAME:
Donor engineered dendritic cells to generate tolerogenic regulatory T cells for renal transplantation

PUBLICATION(s):
Pacheco-Silva, Alvaro
INSTITUTE: Federal University São Paulo, Brazil

PROPOSAL NAME:
Protective genes expression and its modulation by immunosuppressive drugs in kidney transplant recipients
Phillips, Carrie
INSTITUTE: Indiana University School of Medicine, USA

PROPOSAL NAME:
Epithelial proteins contributing to infantile nephronophthisis
Smith, Kenneth GC
INSTITUTE: Cambridge Institute, UK

PROPOSAL NAME:
Gene expression profiling to target immunosuppressive therapy in lupus nephritis
Williams, Julie
INSTITUTE: University of Birmingham, UK

PROPOSAL NAME:
Mechanisms of induction of disrupted neutrophil function after binding of antineutrophil cytoplasm antibodies to proteinase 3 and co-receptors

PUBLICATION(s):
Wong, Wilson
INSTITUTE: Guy's Hospital, London, UK

PROPOSAL NAME:
Passenger dendritic leukocytes in tolerance and rejection

PUBLICATION(s):
Brown K, Moxham V, Karegli J, et al. Ultra-Localization of Foxp3 T Cells within Renal Allografts Shows Infiltration of Tubules Mimicking Rejection. The American Journal of Pathology. 2007:171; 1915-1922.
Brown K and Wong W. Diagnostic Value of Regulatory T Cells: A New Facet of a Much Studied Cell Population. Transplantation. 2008;86:Transplantation. 2008 Dec 15;86(11):1485-91
Brown K and Wong W. Monitoring Regulatory T-Cells after Transplantation: Is It Useful. Trends in Transplant. 2009;3:119-28.
2003 - Cycle 2
Amann, Kerstin Ute
INSTITUTE: University Erlangen-Nürnberg, Germany

PROPOSAL NAME:
Pathogenesis and morphology of atherosclerosis in renal disease
Fontés, Michel
INSTITUTE: IPHM, Marseilles, France

PROPOSAL NAME:
Preclinical models of ADPKD: Exploration and new therapeutic targets
Jaisser, Frédéric
INSTITUTE: Inserm Avenir Collège de France

PROPOSAL NAME:
Unraveling the pathophysiological role of aldosterone in kidney diseases: Molecular and functional studies in conditional transgenic animals
Jonsson, Kenneth
INSTITUTE: Uppsala University, Sweden

PROPOSAL NAME:
FGF-23 and sFRP-4--new phosphate regulating hormones?

PUBLICATION(s):
Marsell R, Krajisnik T, Goransson H, et al. Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23. Nephrol Dial Transplant. 2008 Mar;23(3):827-33.
Kronenberg, Florian
INSTITUTE: Inst Med Biol & Human Genetics, Austria

PROPOSAL NAME:
Genetic influence on HDL cholesterol and triglyceride concentrations in hemodialysis patients and its association with atheroscerotic complications
Morigi, Marina
INSTITUTE: Mario Negri Institute, Bergamo, Italy

PROPOSAL NAME:
Role of complement in tubulointerstitial injury of proteinuric nephropathy

PUBLICATION(s):
Buelli S, Abbate M, Morigi M, et al. Protein load impairs factor H binding promoting complement-dependent dysfunction of proximal tubular cells. Kidney International. 75:1050-1059. 2009.
O'Neill, W. Charles
INSTITUTE: Emory University, Atlanta, GA USA

PROPOSAL NAME:
Role of pyrophosphate in the vascular calcification of renal failure

PUBLICATION(s):
Lomashvili K, Cobbs S, Hennigar R, et al. Phosphate-Induced Vascular Calcification: Role of Pyrophosphate and Osteopontin. J Am Soc Nephrol. 2004;15: 1392–1401.
Lomashvili K, Khawandi W, and O’Neill WC. Reduced Plasma Pyrophosphate Levels in Hemodialysis Patients. the American Society of Nephrology. 2005;1046-6673/1608-2495.
Lomashvili K, Garg P and WC O’Neill. Chemical and hormonal determinants of vascular calcification in vitro. Kidney International. 2006;69, 1464–1470.
O'Neill WC. The fallacy of calcium-phosphorus product. Kidney International. 2007;72, 792–796;
Lomashvili K, Garg P, Narisawa S, et al. Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcification. Kidney International. 2008; doi:10.1038/ki.2008.26.
O'Neill WC. Treatment of vascular calcification. Kidney International. 2008;74, 1376–1378.
Lomashvili K, Monier-Faugere M, Wang X, et al. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney International. 2009;75, 617-625.
Sandberg, Kathryn
INSTITUTE: Georgetown University, Wash DC USA

PROPOSAL NAME:
Investigations into gonadal hormone regulation of progressive renal disease

PUBLICATION(s):
Ji H, Pesce C, Zheng W, et al. Sex differences in renal injury and nitric oxide production in renal wrap hypertension. Am J Physiol Heart Circ Physiol. 2005;288: H43–H47, 2005.
Zheng, Feng
INSTITUTE: Mount Sinai School of Medicine, NY, USA

PROPOSAL NAME:
Mesangial cell progenitor and aging glomerulosclerosis
2002 - Cycle 1
Alpers, Charles
INSTITUTE: University of Washington, Seattle, USA

PROPOSAL NAME:
Characterization in inflammatory responses in membranoproliferative (cryoglobulinemic) glomerulonephritis

PUBLICATION(s):
Muhlfeld A, Segerer S, Hudkins K, et al. Deletion of the Fc Receptor IIb in Thymic Stromal Lymphopoietin Transgenic Mice Aggravates Membranoproliferative Glomerulonephritis. American Journal of Pathology. 2003;Vol. 163 No. 3.
Taneda S, Hudkins K, Muhlfeld A, et al. Protease Nexin-1, tPA, and PAI-1 are Upregulated in Cryoglobulinemic Membranoproliferative Glomerulonephritis. J Am Soc Nephrol. 2008;19: 243–251.
Argilés, Àngel
INSTITUTE: Institut de Genetique Humaine, France

PROPOSAL NAME:
Transcriptome based characterisation of the molecular mechanisms involved in the renal cell response to ischemia. A central feature in acute renal failure and in renal transplantation
Benigni, Ariela
INSTITUTE: Mario Negri Institute, Bergamo, Italy

PROPOSAL NAME:
Gene delivery by 2nd generation adenovirus or adeno associated virus to donor kidney to prolong survival and induce donor-specific tolerance in a rat renal allograft model

PUBLICATION(s):
Guan, Youfei
INSTITUTE: Vanderbilt University Medical Ctr, TN USA

PROPOSAL NAME:
Role of peroxisome proliferator-activated receptor y(PPARy) in diabetic nephropathy
Guebre-Egziabher, Fitsum
INSTITUTE: Hopital Edouard Herriot, Lyon, France

PROPOSAL NAME:
Anti-inflammatory effects of N-3 fatty acids in chronic renal failure patients
Lan, Hui Yao
INSTITUTE: Baylor College of Medicine, TX USA

PROPOSAL NAME:
Gene therapy for diabetic nephropathy using ultrasound-microbubble-mediated transfer of inducible smad7
Mayer, Gert
INSTITUTE: Universität Innsbruck, Austria

PROPOSAL NAME:
Telomere shortening as a determinant for allograft function in human renal transplantation

PUBLICATION(s):
Koppelstaetter C, Schratzberger G, Preco P, et al. Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell. 2008;Aug 7(4):491-7.
Pontoglio, Marco
INSTITUTE: Institut Pasteur, Paris, France

PROPOSAL NAME:
Identifying HNF1B target genes in renal dysplasia

PUBLICATION(s):
Gresh L, Fischer E, Reimann A, et al. A transcriptional network in polycystic kidney disease. The EMBO Journal. 2004;23, 1657–1668.
Fischer E, Legue E, Doyen A, et al. Defective planar cell polarity in polycystic kidney disease. Nature Genetics. 2006;Vol 38, No. 1.
Contact

For questions regarding the GRIP application process, please email our Grant Program Administrator.

Genzyme Terms and Conditions | Privacy Policy Genzyme Corporation. All rights reserved.